EPISODE · Jun 20, 2024 · 50 MIN
Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
from Diffuse Large B-Cell Lymphoma CancerCare Connect Education Workshops
- Overview of Diffuse Large B-Cell Lymphoma (DLBCL), Including Staging and Grading, In the Context of COVID, Seasonal Flu and RSV - Current Standard of Care, New & Emerging Treatment Approaches - Treatment Options for Relapsed Refractory DLBCL, Including Bispecific Antibodies - Understanding How Bispecific Antibodies Work in the Treatment of Relapsed Refractory DLBCL - The Role of Clinical Trials: How Research Contributes to Treatment Options - Tips to Prevent & Manage Treatment Side Effects, Symptoms, Discomfort & Pain - Talking with Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions for Our Panel of Experts
NOW PLAYING
Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
No transcript for this episode yet
Similar Episodes
Oct 3, 2025 ·28m
Sep 16, 2025 ·29m
Sep 16, 2025 ·47m
Sep 12, 2025 ·37m
Sep 11, 2025 ·40m
Sep 10, 2025 ·40m